X @Forbes
Forbes·2025-08-07 13:55
For years, Jake Becraft has been working at the bleeding edge of cancer research. Now, with solid early clinical results and a boatload of cash he’s hoping to bring his first innovative therapeutic to market by 2030. (Photo: John Chomitz)https://t.co/4I0OUSwHHL https://t.co/3R9MFesb0V ...